Dynamic molecular monitoring reveals that SWI–SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphomaRishu Agarwal, Sarah‐Jane Dawson, Yih-Chih Chan et al.|Nature Medicine|2018Cited by 204
First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation StudyAmit Khot, Simon J. Harrison, Natalie Brajanovski et al.|Cancer Discovery|2019Cited by 201
Germ line<i>DDX41</i>mutations define a unique subtype of myeloid neoplasmsHideki Makishima, Jaroslaw P. Maciejewski, Pramila Krishnamurthy et al.|Blood|2022Cited by 142
Enhancer retargeting of <i>CDX2</i> and <i>UBTF::ATXN7L3</i> define a subtype of high-risk B-progenitor acute lymphoblastic leukemiaShunsuke Kimura, Charles G. Mullighan, Lindsey E. Montefiori et al.|Blood|2022Cited by 50